000 01467 a2200457 4500
005 20250514011956.0
264 0 _c20011204
008 200112s 0 0 eng d
022 _a0163-4356
024 7 _a10.1097/00007691-200110000-00006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChristensen, J
245 0 0 _aPlasma concentration of topiramate correlates with cerebrospinal fluid concentration.
_h[electronic resource]
260 _bTherapeutic drug monitoring
_cOct 2001
300 _a529-35 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAnticonvulsants
_xblood
650 0 4 _aBlood-Brain Barrier
650 0 4 _aBrain
_xmetabolism
650 0 4 _aCarbamazepine
_xanalogs & derivatives
650 0 4 _aDrug Monitoring
650 0 4 _aDrug Therapy, Combination
650 0 4 _aEpilepsy
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aFructose
_xanalogs & derivatives
650 0 4 _aHumans
650 0 4 _aLamotrigine
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOxcarbazepine
650 0 4 _aProspective Studies
650 0 4 _aTopiramate
650 0 4 _aTriazines
_xblood
700 1 _aHøjskov, C S
700 1 _aDam, M
700 1 _aPoulsen, J H
773 0 _tTherapeutic drug monitoring
_gvol. 23
_gno. 5
_gp. 529-35
856 4 0 _uhttps://doi.org/10.1097/00007691-200110000-00006
_zAvailable from publisher's website
999 _c11512052
_d11512052